Beaumont Asset Management, L.L.C. Gilead Sciences, Inc. Transaction History

Beaumont Asset Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $566,556 - $645,564	-10,001 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$62.1 - $78.08 $17,201 - $21,628	-277 Reduced 2.7%	10,001 $632,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $311,351 - $361,536	-4,304 Reduced 29.52%	10,278 $790,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $5,135 - $6,578	-82 Reduced 0.56%	14,582 $1.09 Million
Q4 2019 Jan 29, 2020	BUY	$61.62 - $67.78 $903,595 - $993,925	14,664 New	14,664 $952,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Beaumont Asset Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Beaumont Asset Management, L.L.C. with notifications on news.